Live News NEWS FLASH L impact Sep 21, 2026, 11:30 AM UTC Novo Nordisk CSO: We Believe Nextgen GLP-1 To Be Potentially Differentiated Across Efficacy, Convenience, Safety, Tolerability SquawkNews Desk